If a medication is available in the US but not in your country, read When conventional access fails.

Step 1, You submit a request

A patient, a family member, or the treating physician submits a request indicating the drug name, the indication, the destination country, and basic patient information. Requests can be submitted via our website form, by email, or by direct physician outreach.

Step 2, Clinical & regulatory review

Our clinical team reviews the request to confirm: (a) the drug is FDA-approved and available through US wholesaler channels; (b) the destination country has an established Named Patient Program or personal-import pathway; (c) the patient has, or can obtain, a prescription from a licensed physician in their country; and (d) the indication is clinically appropriate.

Step 3, Eligibility & pricing

We respond with eligibility confirmation, the specific destination-country pathway we will use, documentation required from the prescribing physician, expected pricing, and an estimated timeline. Patients can ask questions or cancel at any point before payment.

Step 4, Physician authorization

The patient's treating physician provides: the prescription, a clinical justification (required in most NPP pathways), and any destination-country forms. We help the physician prepare these documents; we do not replace the physician.

Step 5, Regulatory filing (where required)

For destination countries requiring MoH or regulator-level approval, we coordinate the filing with the physician and patient. This step may take days to weeks depending on country.

Step 6, Prepayment

Patients prepay for the drug. This is the industry standard for NPP and keeps the pathway transparent. We never place an order until payment clears.

Step 7, Sourcing & serialization

We procure the drug from a DSCSA-compliant US specialty wholesaler. Every unit is serialized. The chain-of-custody is digitally recorded from wholesaler to destination.

Step 8, Cold-chain shipping

We ship via specialized cold-chain carriers to the destination address, typically the patient's treating physician or a hospital pharmacy. We monitor the shipment in real time.

Step 9, Delivery & follow-up

On delivery, the receiving physician confirms receipt and storage. For drugs requiring administration, the physician oversees. We follow up within 48 hours to confirm safe receipt.

Step 10, Adverse event reporting

We operate pharmacovigilance workflows. If a patient experiences any adverse event, the treating physician should report to us and we will support reporting to the drug manufacturer and relevant regulators.